全球多菌株益生菌市場 - 2023-2030
市場調查報告書
商品編碼
1359943

全球多菌株益生菌市場 - 2023-2030

Global Multistrain Probiotics Market - 2023-2030

出版日期: | 出版商: DataM Intelligence | 英文 186 Pages | 商品交期: 約2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述 :

2022年,全球多菌株益生菌市場達到730億美元,預計2030年將達到1,371億美元,2023-2030年預測期間複合年成長率為8.2%。

多菌株益生菌中存在多種細菌菌株。經常食用可以使腸道保持健康狀態。由於它是一種安全產品,可以針對疾病和傳染源提供治療和保護屏障,因此多菌株益生菌的使用越來越受歡迎。由於不同菌株之間的協同作用和累加效應,多菌株益生菌也比單菌株益生菌更健康。

多菌株益生菌市場可能在未來幾年保持成長勢頭,因為它們具有更廣泛的功效和協同效應。此外,由於人們越來越了解多菌株益生菌對免疫、消化系統和整體健康的影響,因此對多菌株益生菌的需求不斷增加。領先的益生菌製造商正在利用消費者可支配收入的增加和飲食意識的提高,努力提高其各種多菌株益生菌的銷售利潤。

亞太地區主導全球多菌株益生菌市場,2022 年收入佔有率為 46.5%。亞太地區多菌株益生菌市場受到不斷成長的消費者需求、媒體關注和新技術意識的推動。中國和印度益生菌意識的不斷增強預計將加速該地區市場的成長。

動態:

提高健康意識

隨著消費者腸道健康意識的增強,對多菌株益生菌的需求預計將會增加。隨著保持健康的腸道對消費者變得越來越重要,近年來,主要參與者積極提供益生菌食品、飲料和補充劑。隨著越來越多的消費者接受腸道健康與身體健康、體重管理和能量維持之間的聯繫,預計未來幾年益生菌的需求將會增加。健康飲食趨勢的興起以及人們對營養對健康影響的認知不斷增強,促使製造商生產和銷售具有特定健康聲明的食品。西方市場的消費者對健康生活採取全面的態度,益生菌的消費量正在增加。

為了向消費者提供高品質的益生菌產品,製造商正在嘗試添加免疫益處的益生菌的配方和生產。多菌株配方、菌株特異性製劑等方面的工作正在進行中。例如,益生菌飲料和補充劑公司 GoodBellyProbiotics 於 2022 年 8 月推出了新的免疫支持產品線,其中包括誇脫飲料和注射。 GoodBellyImmune Support Shots 的鳳梨、百香果、檸檬、生薑和薑黃口味含有與誇脫相同的益生菌菌株。

國際組織參與益生菌產品研發

多菌株益生菌對人類和動物的健康優勢在全球範圍內得到認可。世界衛生組織、IPA 以及國際益生菌和益生元科學協會等國際組織正在提高人們對益生菌的認知,因為益生菌的益處越來越多。益生菌研發的監管和投資政策由協會與各國政府合作制定,推動了多菌株益生菌市場的發展。此外,益生菌研究也取得了重大進展,提高了人們對各種菌株的作用及其潛在健康優勢的了解。益生菌產業越來越有興趣利用科學進步來創造具有特定特徵和功能的菌株。

開發新益生菌菌株的研發成本高昂

多菌株益生菌市場的發展受到研發活動、實驗室、研究設備的大量投資以及僱用合格員工的高成本的阻礙。益生菌菌株和產品的開發和生產遵循國際食品法規。由於生產成本高,所以成品價格也高。不同的分銷管道用於行銷和分銷益生菌產品。它們也有各種包裝。因此,這些因素提高了產品的成本,使其變得更加昂貴,進而抑制了消費者的購買行為,為產業參與者帶來了挑戰。

目錄

第 1 章:方法與範圍

  • 研究方法論
  • 報告的研究目的和範圍

第 2 章:定義與概述

第 3 章:執行摘要

  • 按應用程式片段
  • 最終使用者的片段
  • 按地區分類的片段

第 4 章:動力學

  • 影響因素
    • 動力
      • 提高健康意識
      • 國際組織參與益生菌產品研發
    • 限制
      • 開發新益生菌菌株的研發成本較高
    • 機會
    • 影響分析

第 5 章:產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • 俄烏戰爭影響分析
  • DMI 意見

第 6 章:COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆發前的情景
    • 新冠疫情期間的情景
    • 新冠疫情後的情景
  • COVID-19 期間的定價動態
  • 供需譜
  • 疫情期間政府與市場相關的舉措
  • 製造商策略舉措
  • 結論

第 7 章:按應用

  • 食品和飲料
  • 動物飼料
  • 膳食補充劑

第 8 章:最終用戶

  • 人類
  • 動物

第 9 章:按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 亞太其他地區
  • 中東和非洲

第 10 章:競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 11 章:公司簡介

    • 養樂多本社株式會社
    • 公司簡介
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • 鹿蘭酶公司
  • 蛋白質
  • 丹尼斯克
  • 蓋亞生物
  • 科。漢森
  • 達弗龍有限公司
  • 拉勒曼德公司
  • 普羅比公司
  • Innovix Labs 清單並非詳盡無遺

第 12 章:附錄

簡介目錄
Product Code: FB6995

Overview:

Global Multistrain Probiotics Market reached US$ 73 billion in 2022 and is expected to reach US$ 137.1 billion by 2030, growing with a CAGR of 8.2% during the forecast period 2023-2030.

Multiple bacterial strains are present in multistrain probiotics. Regular consumption keeps the gut in a healthy state. Because it is a safe product that provides a therapeutic and protective barrier against diseases and infectious agents, the use of multistrain probiotics is growing in popularity. Due to the synergy and additive effects between the various isolates, multistrain probiotics are also significantly healthier than single-strain probiotics.

The market for multistrain probiotics is likely to maintain its momentum in the coming years because they suggest a wider spectrum of efficacy and synergistic effects. In addition, there is a rising need for multistrain probiotics due to growing knowledge about their effects on immunity, the digestive system, and overall wellness. Leading probiotics manufacturers are working to increase the profitability of sales of their wide range of multistrain probiotics by taking advantage of consumers' rising disposable income and increasing dietary awareness.

Asia Pacific dominated the global multistrain probiotics market with revenue share of 46.5% in the year 2022. The Asia-Pacific multistrain probiotics market is driven by rising consumer demand, media attention, and awareness of new technology. Growing probiotic awareness in China and India is anticipated to accelerate the growth of the regional market.

Dynamics:

Increasing Awareness About Health

The demand for multistrain probiotics is anticipated to increase as consumer awareness of gut health increases. As maintaining a healthy gut becomes more crucial to consumers, major players have actively offered probiotic food, drinks, and supplements in recent years. Probiotic demand is anticipated to rise in the coming years as more consumers accept the connection between gut health and physical health, weight management, and energy maintenance. The production and marketing of food with specific health claims by manufacturers is prompted by rising trends towards healthier diets and growing awareness of the impact of nutrition on health. Western markets, where consumers adopt a holistic approach to healthy living, are seeing an increase in probiotic consumption.

To provide consumers with high-quality probiotic products, manufacturers are experimenting with the formulation and production of probiotics with the added immunity benefits. Work is being done on multi-strain formulations, strain-specific formations, etc. For instance, the probiotic beverage and supplement company GoodBellyProbiotics unveiled its new Immune Support product line in August 2022, which includes quart beverages and shots. The pineapple, passionfruit, lemon, ginger, and turmeric flavours of the GoodBellyImmune Support Shots contain the same probiotic strains that the quarts do.

International Organisations' Involvement in Probiotic Products Research and Development

The health advantages of multistrain probiotics for both humans and animals are acknowledged on a global scale. International organisations like the WHO, IPA, and the International Scientific Association for Probiotics and Prebiotics are raising awareness about probiotics due to their growing benefits. The regulation and investment policies for probiotic R&D are drafted by associations in collaboration with national governments, which in turn drives the multistrain probiotics market. Additionally, there have been significant advancements in probiotic research, which have improved the understanding of the workings of various strains and their potential health advantages. The probiotic industry is increasingly interested in using scientific advancements to create strains with particular characteristics and capabilities.

High R&D Costs for Developing New Probiotic Strains

The development of the multistrain probiotics market is hindered by significant investments in R&D activities, laboratories, research equipment, and the high cost of hiring qualified employees. International food regulations are followed in the development and production of probiotic strains and products. Due to the high cost of production, the price of the finished product is high. Different channels of distribution are used for marketing and distributing probiotic products. They come in various packaging as well. Thus, these factors raise the cost of the product, making it more expensive, which in turn restrains consumer purchasing behaviour and presents a challenge for industry players.

Segment Analysis:

The global multistrain probiotics market is segmented based on application, end-user and region.

Enzymes and Probiotics are Being Added to Food and Beverage Products by Manufacturers More Frequently

The segment is anticipated to grow as a result of rising consumer demand for food products with higher nutrient and fibre contents. Probiotics and other digestive ingredients are frequently used in fish oil and yoghurt to lower the risk of issues with gut health. Probiotics have become more popular among consumers as a remedy for their health problems as a result of rising disposable incomes and a growing awareness of ways to improve quality of life. Due to the rising demand for probiotics in foods and drinks, manufacturers are growing their operations. For instance, Korea's Hy Co, formerly known as Korea Yakult, announced in August 2022 that it would be expanding into probiotic business categories to offer a wider range of products.

Geographical Penetration:

In Asia Pacific, Disposable Incomes are Rising, Standards of Living are Rising, and Acceptance of Functional Foods is Growing

Due to growing awareness of fitness and maintaining good digestive health, consumers in this region are becoming more and more interested in healthy products. In addition, there is a growing market for products that support a healthy gut microbiome due to the growing significance of gut health in overall wellbeing. Multistrain probiotic supplements are becoming more and more well-liked among the region's health-conscious consumers because they are thought to be an easy and efficient way to add beneficial bacteria to the gut. The demand for multistrain probiotics in infant formula has been extremely high in China and is expected to continue to rise over the next few years. Due to an ageing population, a growing awareness of the value of preventive healthcare, and numerous studies demonstrating the advantages of these products for immunity, cognitive health, and skincare, the market in Asia Pacific has experienced significant growth.

COVID-19 Impact Analysis:

The COVID-19 pandemic has increased understanding of the value of a robust immune system. To support their immune systems, many consumers have turned to dietary supplements, such as multistrain probiotics. The marketing of some multistrain probiotics as immune-boosters has increased demand. Furthermore, the significance of overall health and wellness has been emphasised by COVID-19. Customers are more likely to spend money on products that support overall health, which includes gut health. Multistrain probiotics have benefited from this development because of their potential to support immune and digestive health.

Russia-Ukraine War Impact Analysis:

Supply chains were disrupted by geopolitical tensions and economic sanctions, which had an impact on where raw materials were sourced and how multistrain probiotics were produced. Supply issues result from suppliers or manufacturers being situated in regions that are directly impacted by the conflict. Additionally, the economic unpredictability brought on by the war caused some consumers to cut back on discretionary spending, including on dietary supplements. The sales of multistrain probiotics were impacted by this.

By Application

  • Food and Beverages
  • Animal Feed
  • Dietary Supplements

By End-User

  • Humans
  • Animals

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In March 2023, The FX-856 strain, which lessens the symptoms of diarrhoea, constipation, bloating, and ulcerative colitis, was introduced by the English pharmaceutical company FERRYX Ltd.
  • In May 2023, Roquette unveiled PEARLITOL ProTec, a cutting-edge excipient made with the intention of improving the stability of probiotic supplements.
  • In April 2023, an improved quality specification for the well-known probiotic bacteria LifeinU L. Rhamnosus GG was introduced by Lesaffre's Gnosis.

Competitive Landscape

The major global players in the market: Yakult Honsha Co., Ltd., Deerland Enzymes, Inc., Protexin, Danisco, BioGaia, Chr. Hansen, Daflorn Ltd., Lallemand Inc., Probi AB and Innovix Labs.

Why Purchase the Report?

  • To visualize the global multistrain probiotics market segmentation based on application, end-user, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of multistrain probiotics market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global multistrain probiotics market report would provide approximately 53 tables, 46 figures and 186 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Application
  • 3.2. Snippet by End-User
  • 3.3. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Awareness About Health
      • 4.1.1.2. International Organisations' Involvement in Probiotic Products Research and Development
    • 4.1.2. Restraints
      • 4.1.2.1. High R&D Costs for Developing New Probiotic Strains
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Food and Beverages*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Animal Feed
  • 7.4. Dietary Supplements

8. By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Humans*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Animal

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.5.1. U.S.
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.5.1. Germany
      • 9.3.5.2. UK
      • 9.3.5.3. France
      • 9.3.5.4. Italy
      • 9.3.5.5. Spain
      • 9.3.5.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. Brazil
      • 9.4.5.2. Argentina
      • 9.4.5.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. China
      • 9.5.5.2. India
      • 9.5.5.3. Japan
      • 9.5.5.4. Australia
      • 9.5.5.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

    • 11.1.1. Yakult Honsha Co., Ltd.*
    • 11.1.2. Company Overview
    • 11.1.3. Product Portfolio and Description
    • 11.1.4. Financial Overview
    • 11.1.5. Key Developments
  • 11.2. Deerland Enzymes, Inc.
  • 11.3. Protexin
  • 11.4. Danisco
  • 11.5. BioGaia
  • 11.6. Chr. Hansen
  • 11.7. Daflorn Ltd.
  • 11.8. Lallemand Inc.
  • 11.9. Probi AB
  • 11.10. Innovix Labs LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us